Targeting the tumor cell-intrinsic ITGB2 axis inhibits melanoma progression. - Rasbach E; Migayron L; Brandenburg A; Singh P; Martins C; Kassem A; Karkempetzaki AI; Suessner N; Kulcsar Z; Riopedre J; Silva M; Zhen E; et al. (Molecular cancer, 2025)